Wolde Mussie, Elizabeth,Yang, Rong,Donello, John E.,Schweighoffer, Fabien J.
申请号：
AU2011239238
公开号：
AU2011239238B2
申请日:
2011.10.20
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2011239238B220131010.pdf#####ABSTRACT Ophthalmically therapeutic compositions, such as polymeric drug delivery systems, include a therapeutic component that includes a sirtuin-activating agent, such as resveratrol, which, upon delivery to the posterior segment of a mammalian eye, treats ocular conditions. Methods of making and using the present compositions are also described. C:\NRPonbI\DCC\TZM\3930163_1 DOC - 20/10/11
